ikon MSD CINV App

1.0.3 by moPharma Digital Solutions Pvt. Ltd.


Aug 22, 2015

Tentang MSD CINV App

Indonesia

e-mengelola, MSD App Pengelolaan Kemoterapi Induced Mual & Emesis

Chemotherapy-induced nausea and vomiting (CINV) is one of the most feared side effects of cancer treatment1-3.Inadequately controlled emesis significantly impairs quality of life1.

e-MANAgE is a tool in the form of an App to guide physician in evaluating the emetogenecity level of chemotherapy (single/ combination) administered to their patients and in turn better management of CINV

The concept of the e-MANAgE is to provide a reliable method of predicting the risk of emesis following cancer chemotherapy.

This App is developed by MSD Pharmaceuticals Pvt. Ltd., India.

Copyright © 2015 MSD Pharmaceuticals Pvt. Ltd.,

a subsidiary of Merck Sharp & Dohme Corp.,

Whitehouse Station, N.J., U.S.A. All rights reserved.

ONCO-1142625-0000 25/02/2015 24/02/2016

Reference:

1) Hesketh PJ. Defining the emetogenicity of cancer chemotherapy regimens:

relevance to clinical practice. Oncologist. 1999;4(3):191-6.

2) Coates A, Abraham S, Kaye SB, et al. On the receiving end: patient perception of the side-effects of cancer chemotherapy. Eur J Cancer Clin Oncol. 1983;19(2):203-8.

3) Griffin AM, Butow PN, Coates AS, et al. On the receiving end V: patient perceptions of the side effects of cancer chemotherapy in 1993. Ann Oncol. 1996;7(2):189-95.

Apa yang baru dalam versi terbaru 1.0.3

Last updated on Aug 22, 2015

Minor bug fixes and improvements. Install or update to the newest version to check it out!

Terjemahan Memuat...

Informasi APL tambahan

Versi Terbaru

Permintaan MSD CINV App Update 1.0.3

Diunggah oleh

Sando Prayoga

Perlu Android versi

Android 2.1+

Tampilkan Selengkapnya

MSD CINV App Tangkapan layar

Komentar Loading...
Bahasa
Cari...
Berlangganan APKPure
Jadilah yang pertama mendapatkan akses ke rilis awal, berita, dan panduan dari game dan aplikasi Android terbaik.
Tidak, terima kasih
Mendaftar
Berlangganan dengan sukses!
Anda sekarang berlangganan APKPure.
Berlangganan APKPure
Jadilah yang pertama mendapatkan akses ke rilis awal, berita, dan panduan dari game dan aplikasi Android terbaik.
Tidak, terima kasih
Mendaftar
Kesuksesan!
Anda sekarang berlangganan buletin kami.